AARD (STOCKS)
Aardvark Therapeutics, Inc. Common Stock
$3.955000
+0.015000 (+0.38%)
Prev close: $3.940000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Tien Li Lee
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $86.28M
- Employees
- 31
- P/E (TTM)
- -1.49
- P/B (TTM)
- 0.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
6
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.81 | $-0.85 | +0.0394 | +4.64% |
|
Sep 2025 (Q3)
|
$-0.75 | $-0.81 | +0.0645 | +7.92% |
|
Jun 2025 (Q2)
|
$-0.66 | $-0.61 | -0.0480 | -7.84% |
|
Mar 2025 (Q1)
|
$-0.71 | $-0.69 | -0.0232 | -3.38% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $5.13M |
| Operating Expenses | $62.73M |
| Research and Development | $48.94M |
| Other Operating Expenses | $13.79M |
| Operating Income/Loss | -$62.73M |
| Income/Loss From Continuing Operations After Tax | -$57.59M |
| Income/Loss From Continuing Operations Before Tax | -$57.59M |
| Income Tax Expense/Benefit | $0.00 |
| Interest And Dividend Income, Operating | $5.14M |
| Net Income/Loss | -$57.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$57.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$57.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.93 |
| Diluted Earnings Per Share | -$2.93 |
| Basic Average Shares | 19,624,626 |
| Diluted Average Shares | 19,624,626 |
| Assets | $117.18M |
| Current Assets | $111.89M |
| Cash | $110.00M |
| Other Current Assets | $1.89M |
| Noncurrent Assets | $5.30M |
| Liabilities | $10.55M |
| Current Liabilities | $10.55M |
| Accounts Payable | $2.07M |
| Wages | $2.91M |
| Other Current Liabilities | $5.56M |
| Noncurrent Liabilities | $0.00 |
| Equity | $106.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $106.63M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $117.18M |
| Net Cash Flow From Operating Activities | -$54.17M |
| Net Cash Flow From Operating Activities, Continuing | -$54.17M |
| Net Cash Flow From Investing Activities | -$49.67M |
| Net Cash Flow From Investing Activities, Continuing | -$49.67M |
| Net Cash Flow From Financing Activities | $89.25M |
| Net Cash Flow From Financing Activities, Continuing | $89.25M |
| Net Cash Flow | -$14.59M |
| Net Cash Flow, Continuing | -$14.59M |
| Comprehensive Income/Loss | -$57.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$57.51M |
| Other Comprehensive Income/Loss | -$57.51M |